BREAKTHROUGH T1D
- Country
- United States
- Type
- Beneficiary
- Grants received
- 15
Funding record
- 15 grants on record
- €936,375 awarded in total
- 2015–2025 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
7 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- NOVO NORDISK A/S
- ELI LILLY AND COMPANY LTD
- KATHOLIEKE UNIVERSITEIT LEUVEN
- NOVARTIS PHARMA AG
- REGION HOVEDSTADEN
- SANOFI-AVENTIS DEUTSCHLAND GMBH
- BOEHRINGER INGELHEIM INTERNATIONALGMBH
- KING'S COLLEGE LONDON
Calls from this organisation
No published calls from this organisation.
Grants received
- Research in Europe and Diversity Inclusion
- Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models
- European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception
- INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE
- Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)
- Real-world evidence for decisions in diabetes
- Fostering a European Research Area for Health Research
- Mobile Artificial Intelligence Solution for Diabetes Adaptive Care
- H2O Health Outcomes Observatory
- Stratification of Obesity Phenotypes to Optimize Future Therapy
- Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA
- Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
- Hypoglycaemia - REdefining SOLutions for better liVEs
- Biomarker Enterprise to Attack DKD - Sofia ref.: 115974
- Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.